rxstatShortages › Ioversol

Ioversol shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ioversol is in a widespread shortage in Canada. 2 of 2 reported products are affected. Manufacturers have not committed to a recovery date.
Products affected
2 / 2
In shortage since
Jul 15, 2022
Reports on file
6
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
OPTIRAY 320
68% · SOLUTION · LIEBEL-FLARSHEIM COMPANY LLC
DIN 01900854 · since Jul 15, 2022, no end estimate · Other (Please describe in comments)
Active shortage
OPTIRAY 320
68% · SOLUTION · LIEBEL-FLARSHEIM COMPANY LLC
DIN 01900854 · since Jul 15, 2022, no end estimate · Other (Please describe in comments)
Active shortage
OPTIRAY 320 (ULTRAJECT)
68% · SOLUTION · LIEBEL-FLARSHEIM COMPANY LLC
DIN 02035626 · since Oct 29, 2024, no end estimate · Other (Please describe in comments)
Active shortage
OPTIRAY 320
68% · SOLUTION · LIEBEL-FLARSHEIM COMPANY LLC
DIN 01900854 · since Jul 15, 2022, no end estimate · Shortage of an active ingredient.
Resolved
OPTIRAY 320 (ULTRAJECT)
68% · SOLUTION · LIEBEL-FLARSHEIM CANADA INC
DIN 02035626 · ended Jan 17, 2020 · Disruption of the manufacture of the drug.
Resolved
OPTIRAY 320 (ULTRAJECT)
68% · SOLUTION · LIEBEL-FLARSHEIM CANADA INC
DIN 02035626 · ended Jan 17, 2020 · Disruption of the manufacture of the drug.

What's happening

Ioversol is currently affected by 2 active shortage reports filed with Health Canada by LIEBEL-FLARSHEIM COMPANY LLC.

The reported causes are: other (please describe in comments); shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ioversol is classified under “X-RAY CONTRAST MEDIA, IODINATED” (ATC V08AB).

Recent changes

Common questions

When will Ioversol be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Ioversol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (x-ray contrast media, iodinated)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.